Irvine-based Ellipse Technologies, a developer of minimally invasive treatments for spinal deformities, said Tuesday that it has raised $17.6M in a Series C financing round. The round came form HBM BioVentures and BioStar Ventures, along with current investors WExford Capital and MedFocus Funds. Ellise Technologies develops a medical device which can be adjusted, non-invasively, from outside of the body via remote control. The firm is targeting the device for treatment of spinal scoliosis in children. More information »